We are very pleased to receive this Award in recognition of our efforts to make NextBio an essential resource for life science research and collaboration among scientists and clinicians worldwide
CUPERTINO, Calif. (PRWEB) June 24, 2008
NextBio's unique life science tool empowers researchers and clinicians to search publicly available data, openly share their own research findings and collaborate as never before. "By encouraging 'open biology', this tool aims to shift the mentality of a community accustomed to guarding its data," explains Frost & Sullivan analyst Christi Bird. "Ultimately, NextBio is positioned to drive the industry towards a more open and collaborative approach to scientific research." NextBio's powerful data and literature search engine is used every day by top pharmaceutical companies and tens of thousands of researchers and clinicians worldwide.
In recognizing NextBio for this Award, Frost & Sullivan highlighted the company's commitment to providing a user-friendly, fast and thought-provoking tool for its customers. "NextBio has transformed the way its end-users approach research," explains analyst Christi Bird. "NextBio's customers rave that what was once a tedious task, now takes only minutes." NextBio empowers scientists to easily find correlations in the scientific data and to discover powerful connections and inferences between the publicly available data and their own proprietary experimental results. The Frost & Sullivan research notes that NextBio encourages the generation of unique hypotheses, as researchers can now examine interactions between seemingly disparate species and platforms by using the search engine.
Frost & Sullivan analyst Christi Bird concluded, "With a growth strategy that benefits its customers' research and a strong commitment to driving the industry towards open biology, NextBio is uniquely positioned to accelerate scientific discovery."
"We are very pleased to receive this Award in recognition of our efforts to make NextBio an essential resource for life science research and collaboration among scientists and clinicians worldwide," said Saeid Akhtari, co-founder and Chief Executive Officer of NextBio. He noted that the company had recently made a free version of the NextBio life science search engine available to the general public at http://www.nextbio.com.
The Award is part of Frost & Sullivan's Best Practices Awards program to recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Selection is made by industry analysts who compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research. For more on the award and NextBio's selection please see http://www.frost.com/prod/servlet/ meawards-hall-of-fame-feature.pag?sid=134767799 (Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.)
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.awards.frost.com.
NextBio is a privately held, venture-backed company that provides an innovative search engine specifically for the life science community. NextBio provides instant access and search, user-generated content and collaboration to scientists and clinicians worldwide, enabling them to access and understand the world's life science information to find important new correlations, make discoveries, and generate hypotheses as never before. NextBio is implemented via a Software-as-a-Service (SaaS) model that enables users to search directly or via internal company sites through the NextBio Application Programming Interface (API). The enterprise version of the NextBio search engine is being used in life science R&D and drug development by researchers and clinicians at Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Celgene, Genzyme, Eli Lilly and Company, and Regeneron Pharmaceuticals, among others. For more information on the company, please visit our website at http://www.nextbio.com.